APA (7th ed.) Citation

P, S., G, T., K, G., N, G., B, P., A, A., & R, K. (2025). Clinical efficacy and safety evaluation of drug therapies for the treatment of progressive fibrotic-interstitial lung diseases (PF-ILDs): A network meta-analysis of randomized controlled trials. Expert review of clinical immunology, 21(8), 1135. https://doi.org/10.1080/1744666X.2025.2543473

Chicago Style (17th ed.) Citation

P, Singh, Thampi G, Gupta K, Gangte N, Pattnaik B, Agrawal A, and Kukreti R. "Clinical Efficacy and Safety Evaluation of Drug Therapies for the Treatment of Progressive Fibrotic-interstitial Lung Diseases (PF-ILDs): A Network Meta-analysis of Randomized Controlled Trials." Expert Review of Clinical Immunology 21, no. 8 (2025): 1135. https://doi.org/10.1080/1744666X.2025.2543473.

MLA (9th ed.) Citation

P, Singh, et al. "Clinical Efficacy and Safety Evaluation of Drug Therapies for the Treatment of Progressive Fibrotic-interstitial Lung Diseases (PF-ILDs): A Network Meta-analysis of Randomized Controlled Trials." Expert Review of Clinical Immunology, vol. 21, no. 8, 2025, p. 1135, https://doi.org/10.1080/1744666X.2025.2543473.